Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
Identifieur interne : 001583 ( Ncbi/Checkpoint ); précédent : 001582; suivant : 001584Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
Auteurs : Mark S. Chambers [États-Unis] ; Harris J. Keene ; Béla B. Toth ; James C. Lemon ; Susan C. Gallagher ; Charles G. Martin ; Jack W. MartinSource :
- Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics [ 1079-2104 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Agonistes muscariniques (usage thérapeutique), Analgésiques morphiniques (usage thérapeutique), Bouche édentée (microbiologie), Dent (microbiologie), Douleur (), Débit sécrétoire (), Femelle, Humains, Mâle, Méthode en simple aveugle, Numération de colonies microbiennes, Pilocarpine (usage thérapeutique), Placebo, Projets pilotes, Salive (), Salive (sécrétion), Streptococcus mutans (croissance et développement), Streptococcus mutans (isolement et purification), Tumeurs (), Xérostomie (microbiologie), Xérostomie (étiologie), Études de suivi, Études longitudinales.
- MESH :
- croissance et développement : Streptococcus mutans.
- isolement et purification : Streptococcus mutans.
- microbiologie : Bouche édentée, Dent, Xérostomie.
- sécrétion : Salive.
- usage thérapeutique : Agonistes muscariniques, Analgésiques morphiniques, Pilocarpine.
- étiologie : Xérostomie.
- Adulte d'âge moyen, Douleur, Débit sécrétoire, Femelle, Humains, Mâle, Méthode en simple aveugle, Numération de colonies microbiennes, Placebo, Projets pilotes, Salive, Tumeurs, Études de suivi, Études longitudinales.
English descriptors
- KwdEn :
- Analgesics, Opioid (therapeutic use), Colony Count, Microbial, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Mouth, Edentulous (microbiology), Muscarinic Agonists (therapeutic use), Neoplasms (complications), Pain (prevention & control), Pilocarpine (therapeutic use), Pilot Projects, Placebos, Saliva (drug effects), Saliva (secretion), Secretory Rate (drug effects), Single-Blind Method, Streptococcus mutans (growth & development), Streptococcus mutans (isolation & purification), Tooth (microbiology), Xerostomia (etiology), Xerostomia (microbiology).
- MESH :
- chemical , therapeutic use : Analgesics, Opioid, Muscarinic Agonists, Pilocarpine.
- complications : Neoplasms.
- drug effects : Saliva, Secretory Rate.
- etiology : Xerostomia.
- growth & development : Streptococcus mutans.
- isolation & purification : Streptococcus mutans.
- microbiology : Mouth, Edentulous, Tooth, Xerostomia.
- prevention & control : Pain.
- secretion : Saliva.
- Colony Count, Microbial, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Pilot Projects, Placebos, Single-Blind Method.
Abstract
Opiod- and/or radiation-induced xerostomia in cancer patients is frequently associated with elevated levels of cariogenic mutans streptococci (MS).
DOI: 10.1016/j.tripleo.2004.03.012
PubMed: 15660089
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002A52
- to stream PubMed, to step Curation: 002A52
- to stream PubMed, to step Checkpoint: 002A52
- to stream Ncbi, to step Merge: 001583
- to stream Ncbi, to step Curation: 001583
Links to Exploration step
pubmed:15660089Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.</title><author><name sortKey="Chambers, Mark S" sort="Chambers, Mark S" uniqKey="Chambers M" first="Mark S" last="Chambers">Mark S. Chambers</name><affiliation wicri:level="1"><nlm:affiliation>The University of Texas, M. D. Anderson Cancer Center, (MDACC), Department of Head and Neck Surgery, Houston, Texas 77030-4009, USA. mchamber@mdanderson.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The University of Texas, M. D. Anderson Cancer Center, (MDACC), Department of Head and Neck Surgery, Houston, Texas 77030-4009</wicri:regionArea><wicri:noRegion>Texas 77030-4009</wicri:noRegion></affiliation></author><author><name sortKey="Keene, Harris J" sort="Keene, Harris J" uniqKey="Keene H" first="Harris J" last="Keene">Harris J. Keene</name></author><author><name sortKey="Toth, Bela B" sort="Toth, Bela B" uniqKey="Toth B" first="Béla B" last="Toth">Béla B. Toth</name></author><author><name sortKey="Lemon, James C" sort="Lemon, James C" uniqKey="Lemon J" first="James C" last="Lemon">James C. Lemon</name></author><author><name sortKey="Gallagher, Susan C" sort="Gallagher, Susan C" uniqKey="Gallagher S" first="Susan C" last="Gallagher">Susan C. Gallagher</name></author><author><name sortKey="Martin, Charles G" sort="Martin, Charles G" uniqKey="Martin C" first="Charles G" last="Martin">Charles G. Martin</name></author><author><name sortKey="Martin, Jack W" sort="Martin, Jack W" uniqKey="Martin J" first="Jack W" last="Martin">Jack W. Martin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15660089</idno><idno type="pmid">15660089</idno><idno type="doi">10.1016/j.tripleo.2004.03.012</idno><idno type="wicri:Area/PubMed/Corpus">002A52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A52</idno><idno type="wicri:Area/PubMed/Curation">002A52</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A52</idno><idno type="wicri:Area/PubMed/Checkpoint">002A52</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A52</idno><idno type="wicri:Area/Ncbi/Merge">001583</idno><idno type="wicri:Area/Ncbi/Curation">001583</idno><idno type="wicri:Area/Ncbi/Checkpoint">001583</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.</title><author><name sortKey="Chambers, Mark S" sort="Chambers, Mark S" uniqKey="Chambers M" first="Mark S" last="Chambers">Mark S. Chambers</name><affiliation wicri:level="1"><nlm:affiliation>The University of Texas, M. D. Anderson Cancer Center, (MDACC), Department of Head and Neck Surgery, Houston, Texas 77030-4009, USA. mchamber@mdanderson.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>The University of Texas, M. D. Anderson Cancer Center, (MDACC), Department of Head and Neck Surgery, Houston, Texas 77030-4009</wicri:regionArea><wicri:noRegion>Texas 77030-4009</wicri:noRegion></affiliation></author><author><name sortKey="Keene, Harris J" sort="Keene, Harris J" uniqKey="Keene H" first="Harris J" last="Keene">Harris J. Keene</name></author><author><name sortKey="Toth, Bela B" sort="Toth, Bela B" uniqKey="Toth B" first="Béla B" last="Toth">Béla B. Toth</name></author><author><name sortKey="Lemon, James C" sort="Lemon, James C" uniqKey="Lemon J" first="James C" last="Lemon">James C. Lemon</name></author><author><name sortKey="Gallagher, Susan C" sort="Gallagher, Susan C" uniqKey="Gallagher S" first="Susan C" last="Gallagher">Susan C. Gallagher</name></author><author><name sortKey="Martin, Charles G" sort="Martin, Charles G" uniqKey="Martin C" first="Charles G" last="Martin">Charles G. Martin</name></author><author><name sortKey="Martin, Jack W" sort="Martin, Jack W" uniqKey="Martin J" first="Jack W" last="Martin">Jack W. Martin</name></author></analytic><series><title level="j">Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics</title><idno type="ISSN">1079-2104</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Analgesics, Opioid (therapeutic use)</term><term>Colony Count, Microbial</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Mouth, Edentulous (microbiology)</term><term>Muscarinic Agonists (therapeutic use)</term><term>Neoplasms (complications)</term><term>Pain (prevention & control)</term><term>Pilocarpine (therapeutic use)</term><term>Pilot Projects</term><term>Placebos</term><term>Saliva (drug effects)</term><term>Saliva (secretion)</term><term>Secretory Rate (drug effects)</term><term>Single-Blind Method</term><term>Streptococcus mutans (growth & development)</term><term>Streptococcus mutans (isolation & purification)</term><term>Tooth (microbiology)</term><term>Xerostomia (etiology)</term><term>Xerostomia (microbiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Agonistes muscariniques (usage thérapeutique)</term><term>Analgésiques morphiniques (usage thérapeutique)</term><term>Bouche édentée (microbiologie)</term><term>Dent (microbiologie)</term><term>Douleur ()</term><term>Débit sécrétoire ()</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Numération de colonies microbiennes</term><term>Pilocarpine (usage thérapeutique)</term><term>Placebo</term><term>Projets pilotes</term><term>Salive ()</term><term>Salive (sécrétion)</term><term>Streptococcus mutans (croissance et développement)</term><term>Streptococcus mutans (isolement et purification)</term><term>Tumeurs ()</term><term>Xérostomie (microbiologie)</term><term>Xérostomie (étiologie)</term><term>Études de suivi</term><term>Études longitudinales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Analgesics, Opioid</term><term>Muscarinic Agonists</term><term>Pilocarpine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Saliva</term><term>Secretory Rate</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Streptococcus mutans</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Bouche édentée</term><term>Dent</term><term>Xérostomie</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Mouth, Edentulous</term><term>Tooth</term><term>Xerostomia</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pain</term></keywords><keywords scheme="MESH" qualifier="secretion" xml:lang="en"><term>Saliva</term></keywords><keywords scheme="MESH" qualifier="sécrétion" xml:lang="fr"><term>Salive</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agonistes muscariniques</term><term>Analgésiques morphiniques</term><term>Pilocarpine</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Xérostomie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Colony Count, Microbial</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Longitudinal Studies</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Placebos</term><term>Single-Blind Method</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Douleur</term><term>Débit sécrétoire</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Numération de colonies microbiennes</term><term>Placebo</term><term>Projets pilotes</term><term>Salive</term><term>Tumeurs</term><term>Études de suivi</term><term>Études longitudinales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Opiod- and/or radiation-induced xerostomia in cancer patients is frequently associated with elevated levels of cariogenic mutans streptococci (MS).</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Gallagher, Susan C" sort="Gallagher, Susan C" uniqKey="Gallagher S" first="Susan C" last="Gallagher">Susan C. Gallagher</name><name sortKey="Keene, Harris J" sort="Keene, Harris J" uniqKey="Keene H" first="Harris J" last="Keene">Harris J. Keene</name><name sortKey="Lemon, James C" sort="Lemon, James C" uniqKey="Lemon J" first="James C" last="Lemon">James C. Lemon</name><name sortKey="Martin, Charles G" sort="Martin, Charles G" uniqKey="Martin C" first="Charles G" last="Martin">Charles G. Martin</name><name sortKey="Martin, Jack W" sort="Martin, Jack W" uniqKey="Martin J" first="Jack W" last="Martin">Jack W. Martin</name><name sortKey="Toth, Bela B" sort="Toth, Bela B" uniqKey="Toth B" first="Béla B" last="Toth">Béla B. Toth</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Chambers, Mark S" sort="Chambers, Mark S" uniqKey="Chambers M" first="Mark S" last="Chambers">Mark S. Chambers</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001583 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001583 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:15660089
|texte= Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:15660089" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |